Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgical Window of Opportunity Study of Megestrol Acetate Compared With Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia

NCT04576104 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04576104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04576104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgical Window of Opportunity Study of Megestrol Acetate Compared With Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 29, 2021
Completion date
June 30, 2026
Enrollment
51 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia, endometrial carcinoma